CIK 0001860657 · <br>Emerging growth company
Allarity Therapeutics, Inc.
Sign in to watch- Ticker
- ALLR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 401-426-4664
- Business address
- 24 SCHOOL ST., 2ND FLOOR, BOSTON, MA, 02108
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- NT 10-Q Other NT 10-Q
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- NT 10-Q Other NT 10-Q
- NT 10-K Other NT 10-K
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
Page 2 of 3 · 44 filings